Sectors & IndustriesHealthcareDrug Manufacturers - General
Best General Drug Manufacturer Stocks to Buy Now (2026)
Top general drug manufacturer stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.

Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 9th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
GSK
GSK PLC
$117.64B$58.54N/AN/AN/AN/A-5.19%-16.48%39.93%10.70%
BMY
BRISTOL MYERS SQUIBB CO
$121.90B$59.86$60.180.54%Buy11-5.32%17.47%53.93%11.06%
LLY
ELI LILLY & CO
$979.46B$1,038.27$1.17k12.79%Strong Buy1715.53%26.57%199.20%46.99%
SNY
SANOFI
$118.81B$47.03$58.0023.33%Strong Buy12.02%31.49%16.32%9.14%
GRFS
GRIFOLS SA
$6.38B$9.28$10.007.76%Hold14.46%80.52%15.62%4.29%
AZN
ASTRAZENECA PLC
$317.01B$204.52N/AN/AN/AN/A7.00%25.79%45.88%19.57%
AMGN
AMGEN INC
$197.19B$366.20$346.15-5.47%Buy132.91%22.01%142.44%15.20%
ABBV
ABBVIE INC
$402.08B$227.50$250.2910.02%Strong Buy149.55%137.95%-1,295.13%25.55%
GILD
GILEAD SCIENCES INC
$188.35B$151.81$151.50-0.20%Strong Buy125.03%16.49%64.56%23.76%
MRK
MERCK & CO INC
$295.96B$119.24$121.001.48%Buy135.30%16.37%49.54%19.83%
AMRN
AMARIN CORP PLC
$308.98M$14.86N/AN/AN/AN/A-9.80%N/A101.68%70.72%
OGN
ORGANON & CO
$1.84B$7.06$9.5034.56%Strong Sell31.15%30.56%108.68%7.27%
JNJ
JOHNSON & JOHNSON
$589.34B$244.55$231.94-5.16%Buy166.31%7.23%44.17%18.08%
PFE
PFIZER INC
$156.19B$27.47$28.292.97%Hold7-2.84%16.75%13.28%5.91%
BIIB
BIOGEN INC
$28.69B$195.50$198.781.68%Buy18-1.22%23.87%14.55%9.02%
NVS
NOVARTIS AG
$307.56B$161.18$118.00-26.79%Strong Sell13.81%15.02%47.88%19.91%
SCLX
SCILEX HOLDING CO
$62.66M$8.26N/AN/AN/AN/A170.24%N/A-46.93%30.57%
MIRA
MIRA PHARMACEUTICALS INC
$49.41M$1.18N/AN/AN/AN/AN/AN/A-101.84%-100.72%
MDCX
MEDICUS PHARMA LTD
$21.87M$0.99$27.002,619.03%Strong Buy1N/AN/A-2,616.99%238.71%
NSRX
NASUS PHARMA LTD
$50.46M$5.60$20.50266.07%Strong Buy2N/AN/AN/A-1,697.09%

General Drug Manufacturer Stocks FAQ

What are the best general drug manufacturer stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best general drug manufacturer stocks to buy right now are:

1. Gsk (NYSE:GSK)


Gsk (NYSE:GSK) is the #1 top general drug manufacturer stock out of 20 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Gsk (NYSE:GSK) is: Value: B, Growth: B, Momentum: B, Sentiment: C, Safety: B, Financials: B, and AI: C.

Gsk (NYSE:GSK) has a Due Diligence Score of 36, which is -4 points lower than the general drug manufacturer industry average of 40. Although this number is below the industry average, our proven quant model rates GSK as a "A".

GSK passed 13 out of 38 due diligence checks and has average fundamentals. Gsk has seen its stock return 62.03% over the past year, overperforming other general drug manufacturer stocks by 35 percentage points.

2. Bristol Myers Squibb Co (NYSE:BMY)


Bristol Myers Squibb Co (NYSE:BMY) is the #2 top general drug manufacturer stock out of 20 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bristol Myers Squibb Co (NYSE:BMY) is: Value: A, Growth: C, Momentum: C, Sentiment: C, Safety: A, Financials: B, and AI: C.

Bristol Myers Squibb Co (NYSE:BMY) has a Due Diligence Score of 49, which is 9 points higher than the general drug manufacturer industry average of 40.

BMY passed 17 out of 38 due diligence checks and has strong fundamentals. Bristol Myers Squibb Co has seen its stock return 6.61% over the past year, underperforming other general drug manufacturer stocks by -20 percentage points.

Bristol Myers Squibb Co has an average 1 year price target of $60.18, an upside of 0.54% from Bristol Myers Squibb Co's current stock price of $59.86.

Bristol Myers Squibb Co stock has a consensus Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Bristol Myers Squibb Co, 36.36% have issued a Strong Buy rating, 9.09% have issued a Buy, 45.45% have issued a hold, while 0% have issued a Sell rating, and 9.09% have issued a Strong Sell.

3. Eli Lilly & Co (NYSE:LLY)


Eli Lilly & Co (NYSE:LLY) is the #3 top general drug manufacturer stock out of 20 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Eli Lilly & Co (NYSE:LLY) is: Value: B, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Eli Lilly & Co (NYSE:LLY) has a Due Diligence Score of 58, which is 18 points higher than the general drug manufacturer industry average of 40.

LLY passed 23 out of 38 due diligence checks and has strong fundamentals. Eli Lilly & Co has seen its stock return 18.94% over the past year, underperforming other general drug manufacturer stocks by -8 percentage points.

Eli Lilly & Co has an average 1 year price target of $1,171.06, an upside of 12.79% from Eli Lilly & Co's current stock price of $1,038.27.

Eli Lilly & Co stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 17 analysts covering Eli Lilly & Co, 64.71% have issued a Strong Buy rating, 17.65% have issued a Buy, 17.65% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the general drug manufacturer stocks with highest dividends?

Out of 14 general drug manufacturer stocks that have issued dividends in the past year, the 3 general drug manufacturer stocks with the highest dividend yields are:

1. Organon & Co (NYSE:OGN)


Organon & Co (NYSE:OGN) has an annual dividend yield of 4.82%, which is 2 percentage points higher than the general drug manufacturer industry average of 2.81%. Organon & Co's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Organon & Co's dividend has not shown consistent growth over the last 10 years.

Organon & Co's dividend payout ratio of 31.1% indicates that its high dividend yield is sustainable for the long-term.

2. Sanofi (NASDAQ:SNY)


Sanofi (NASDAQ:SNY) has an annual dividend yield of 4.7%, which is 2 percentage points higher than the general drug manufacturer industry average of 2.81%. Sanofi's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Sanofi's dividend has shown consistent growth over the last 10 years.

Sanofi's dividend payout ratio of 51% indicates that its high dividend yield is sustainable for the long-term.

3. Pfizer (NYSE:PFE)


Pfizer (NYSE:PFE) has an annual dividend yield of 4.7%, which is 2 percentage points higher than the general drug manufacturer industry average of 2.81%. Pfizer's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Pfizer's dividend has shown consistent growth over the last 10 years.

Pfizer's dividend payout ratio of 99.4% indicates that its high dividend yield might not be sustainable for the long-term.

Why are general drug manufacturer stocks up?

General drug manufacturer stocks were up 1.05% in the last day, and up 2.36% over the last week.

We couldn't find a catalyst for why general drug manufacturer stocks are up.

What are the most undervalued general drug manufacturer stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued general drug manufacturer stocks right now are:

1. Organon & Co (NYSE:OGN)


Organon & Co (NYSE:OGN) is the most undervalued general drug manufacturer stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 32 points higher than the general drug manufacturer industry average of 39. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -51.97% in the past year. It has underperformed other stocks in the general drug manufacturer industry by -79 percentage points.

2. Grifols Sa (NASDAQ:GRFS)


Grifols Sa (NASDAQ:GRFS) is the second most undervalued general drug manufacturer stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Grifols Sa has a valuation score of 57, which is 18 points higher than the general drug manufacturer industry average of 39. It passed 4 out of 7 valuation due diligence checks.

Grifols Sa's stock has gained 32.38% in the past year. It has overperformed other stocks in the general drug manufacturer industry by 5 percentage points.

3. Biogen (NASDAQ:BIIB)


Biogen (NASDAQ:BIIB) is the third most undervalued general drug manufacturer stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Biogen has a valuation score of 86, which is 47 points higher than the general drug manufacturer industry average of 39. It passed 6 out of 7 valuation due diligence checks.

Biogen's stock has gained 46.52% in the past year. It has overperformed other stocks in the general drug manufacturer industry by 19 percentage points.

Are general drug manufacturer stocks a good buy now?

40% of general drug manufacturer stocks rated by analysts are a strong buy right now. On average, analysts expect general drug manufacturer stocks to rise by 5.28% over the next year.

26.32% of general drug manufacturer stocks have a Zen Rating of A (Strong Buy), 31.58% of general drug manufacturer stocks are rated B (Buy), 31.58% are rated C (Hold), 5.26% are rated D (Sell), and 5.26% are rated F (Strong Sell).

What is the average p/e ratio of the drug manufacturers - general industry?

The average P/E ratio of the drug manufacturers - general industry is 43.3x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.